19 contract research organizations in our directory list both Pharmacokinetics and Dog among their capabilities, across 7 countries. 19 report GLP capability and 12 report AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 19 CROs. Order rotates daily so no lab is permanently listed first.
Preclinical CRO in West Michigan specializing in targeted CNS delivery. Long track record supporting intrathecal, intracerebroventricular and cisterna magna dosing, CSF and tissue distribution, pharmacokinetics and…
Indian GLP-certified preclinical CRO providing toxicology and safety studies.
South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.
Preclinical GLP toxicology and safety pharmacology across small and large species.
Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.
Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.
Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.
CRO providing DMPK, bioanalysis, toxicology, and related preclinical services.
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.
Integrated CRO/CDMO spanning preclinical to early clinical, including safety assessment and bioanalysis.
Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.
Preclinical in vivo pharmacology and toxicology with aerosol/inhalation expertise.
Global preclinical/clinical CRO with extensive safety assessment, pharmacology, and discovery services.
Nonclinical CRO supporting infectious disease and other in vivo studies; bioanalysis and pathology support.
Large CRO with global preclinical safety assessment, DMPK, and bioanalytical services.
Preclinical CRO offering discovery, DMPK, toxicology, surgical models, and specialty pathology.
Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.
Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.
Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.